Align Technology stock holds steady as analyst targets highlight upside potential
Published on 08/31/2026 at 19:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Align Technology Inc. (US01741R1023) stock is trading in the mid-$150 range as of August 28, 2026, with a recent Nasdaq session showing the shares at $157.58, setting a clear reference point for investors evaluating the company’s valuation and growth prospects. Per a late-August 2026 market-data overview, this price sits well below earlier record highs, underscoring both the recovery potential and the more moderate expectations now embedded in the stock.
Analyst targets imply sizable upside
A fresh late-August 2026 analyst consensus compiled in a recent overview shows an average price target for Align Technology stock of $206.36, explicitly benchmarked against the cited $157.58 Nasdaq close on August 28, 2026. The difference of $48.78 between the target and the observed price translates into an implied upside of nearly 31 percent, quantifying how current analyst models see room for further gains if execution and demand trends remain supportive.
The same compilation indicates that Align Technology shares are trading well below their historical peak levels, with one evaluation of long-term price data stating that the current $157.58 figure is 78.63 percent under a prior record high. This large gap between the latest quoted price and past extremes places the stock firmly in a consolidation phase, where sentiment appears steadier but investors still weigh the potential for renewed momentum against competitive and macroeconomic risks.
Recent earnings and business trajectory
While the latest half-year and quarterly financials for Align Technology are not detailed in the same late-August 2026 market-data snapshots, the pricing and analyst context make clear that current views are anchored in recent earnings cycles and updated guidance rather than outdated historical numbers. The focus on valuation spreads and the explicit comparison between present trading levels and prior highs shows that recent earnings, cash flow generation, and margin trends are being evaluated collectively, particularly as investors assess whether Align Technology can sustain double-digit growth in clear aligners and digital orthodontic solutions.
Against this backdrop, consensus targets around the $206 mark suggest that forecasts factor in continued demand for premium orthodontic treatments and ongoing investments in digital scanning and treatment-planning technologies. For investors, the standout comparison is the roughly one-third gap between the August 28, 2026 closing price and the average target level, which encapsulates the market’s current expectation that revenue growth, profitability, and cash generation will support a higher valuation over the medium term.
Product spotlight: digital orthodontic solutions
Align Technology’s core business centers on advanced orthodontic treatment systems and associated software platforms, combining customized clear aligner trays with digital imaging and 3D treatment planning to move teeth in a controlled and predictable way. These solutions aim to deliver both clinical efficiency for dentists and orthodontists and improved comfort and aesthetics for patients, while also generating recurring revenue through follow-up treatments, replacement trays, and complementary digital services.
Latest trading snapshot
Align Technology stock is listed on the Nasdaq exchange under the ticker ALGN, and the most recent referenced session in late August 2026 shows the shares at $157.58 as of the August 28, 2026 close. At that level, the stock trades well below its historic peak and broadly in line with the mid-$150 range indicated by late-August trading overviews, providing investors with a concrete price anchor when comparing current valuation metrics with analyst expectations and previous highs.
Fact box
Company: Align Technology Inc.
ISIN: US01741R1023
Ticker: ALGN
Exchange: Nasdaq
Price (as of August 28, 2026, 4:00 p.m. ET): $157.58 USD
Sector / Industry: Healthcare equipment and supplies
Index membership: Nasdaq-100
